| Product Code: ETC13137067 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Opioid Induced Constipation Drugs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Opioid Induced Constipation Drugs Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 North America Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 North America Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 North America Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.7 North America Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 North America Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 North America Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 North America Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Opioid Induced Constipation Drugs Market Trends |
6 North America Opioid Induced Constipation Drugs Market, 2021 - 2031 |
6.1 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Naloxegol, 2021 - 2031 |
6.1.3 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Lubiprostone, 2021 - 2031 |
6.1.4 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Methylnaltrexone Bromide, 2021 - 2031 |
6.1.5 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Docusate Sodium, 2021 - 2031 |
6.1.6 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Over The Counter Medicines, 2021 - 2031 |
6.2.3 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Prescription, 2021 - 2031 |
6.2.4 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Natural Remedies, 2021 - 2031 |
6.3 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3.4 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.2 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Speciality Centres, 2021 - 2031 |
6.4.5 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.4 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Opioid Induced Constipation Drugs Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.1 United States (US) Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.2 Canada Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.3 Rest of North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.3 North America Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
7.3.1 United States (US) Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.2 Canada Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.3 Rest of North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.1 United States (US) Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.2 Canada Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.3 Rest of North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.5 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.1 United States (US) Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.2 Canada Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.3 Rest of North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6 North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.1 United States (US) Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.2 Canada Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.3 Rest of North America Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Opioid Induced Constipation Drugs Market Key Performance Indicators |
9 North America Opioid Induced Constipation Drugs Market - Export/Import By Countries Assessment |
10 North America Opioid Induced Constipation Drugs Market - Opportunity Assessment |
10.1 North America Opioid Induced Constipation Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
10.3 North America Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10.4 North America Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10.5 North America Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10.6 North America Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Opioid Induced Constipation Drugs Market - Competitive Landscape |
11.1 North America Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2022 |
11.2 North America Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here